Jazz Pharmaceuticals plc
US ˙ NasdaqGS ˙ IE00B4Q5ZN47

SecurityJAZZ / Jazz Pharmaceuticals plc
InstitutionSavant Capital, LLC
Latest Disclosed Ownership4,503 shares
Latest Disclosed Value $ 851,293
Savant Capital, LLC reports 11.41% increase in ownership of JAZZ / Jazz Pharmaceuticals plc

On May 4, 2026 - Savant Capital, LLC filed a 13F-HR form disclosing ownership of 4,503 shares of Jazz Pharmaceuticals plc (US:JAZZ) valued at $851,292 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 10, 2026 disclosing 4,042 shares of Jazz Pharmaceuticals plc. This represents a change in shares of 11.41% during the quarter. The current value of the position is $1,074,281 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-04 2026-03-31 13F JAZZ PHARMACEUTICALS SHS USD G50871105 4,503 461 11.41 851 23.87 0.0041
2026-02-10 2025-12-31 13F JAZZ PHARMACEUTICALS SHS USD G50871105 4,042 797 24.56 687 60.89 0.0039
2026-03-04 2025-09-30 13F/A-1 JAZZ PHARMACEUTICALS SHS USD G50871105 3,245 1,024 46.11 428 81.70 0.0026
2025-11-05 2025-09-30 13F JAZZ PHARMACEUTICALS SHS USD G50871105 4,155 1,934 548 0.0029
2025-08-06 2025-06-30 13F JAZZ PHARMACEUTICALS SHS USD G50871105 2,221 -463 -17.25 236 -29.43 0.0015
2026-03-04 2025-03-31 13F/A-1 JAZZ PHARMACEUTICALS SHS USD G50871105 2,684 476 21.56 333 22.88 0.0028
2025-05-08 2025-03-31 13F JAZZ PHARMACEUTICALS SHS USD G50871105 3,022 814 375 0.0027
2025-01-29 2024-12-31 13F JAZZ PHARMACEUTICALS SHS USD G50871105 2,208 2,208 272 0.0021
2024-08-05 2024-06-30 13F JAZZ PHARMACEUTICALS SHS USD G50871105 0 -12,462 -100.00 0 -100.00
2024-05-06 2024-03-31 13F JAZZ PHARMACEUTICALS SHS USD G50871105 12,462 12,462 1,501 0.0172
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.